Frank Ruebsam

503 citations

13 papers · 205 indexed · h-index 7

Co-authors: Peter S. Dragovich Douglas E. Murphy Lian‐Sheng Li Yuefen Zhou Matthew Clark Zhongxiang Sun Eric A. Sigel Heather A. Thomson
Topics: Quinazolinone synthesis and applications (5 papers)Hepatitis C virus research (4 papers)HIV/AIDS drug development and treatment (4 papers)
Cited by: Hepatology Organic Chemistry Computational Theory and Mathematics
Journals: Journal of Medicinal Chemistry Tetrahedron Tetrahedron Letters
Partner nations: China Germany United States

In The Last Decade

Frank Ruebsam

13 papers receiving 185 citations

Peers

Countries citing papers authored by Frank Ruebsam

Since Specialization

Citations

This map shows the geographic impact of Frank Ruebsam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank Ruebsam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank Ruebsam more than expected).

Fields of papers citing papers by Frank Ruebsam

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank Ruebsam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank Ruebsam. The network helps show where Frank Ruebsam may publish in the future.

Co-authorship network of co-authors of Frank Ruebsam

This figure shows the co-authorship network connecting the top 25 collaborators of Frank Ruebsam. A scholar is included among the top collaborators of Frank Ruebsam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frank Ruebsam. Frank Ruebsam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	Novel Autotaxin Inhibitor for the Treatment of Idiopathic Pulmonary Fibrosis: A Clinical Candidate Discovered Using DNA-Encoded Chemistry 2020 ·Journal of Medicinal Chemistry ·John W. Cuozzo,Matthew Clark,Anthony D. Keefe,Anna Kohlmann,Mark J. Mulvihill,Haihong Ni,Louis M. Renzetti,Daniel I. Resnicow,Frank Ruebsam,Eric A. Sigel,Heather A. Thomson,Ce Wang,Zhifeng Xie,Ying Zhang	79
2	Hexahydro-pyrrolo- and hexahydro-1H-pyrido[1,2-b]pyridazin-2-ones as potent inhibitors of HCV NS5B polymerase 2008 ·Bioorganic & Medicinal Chemistry Letters ·Frank Ruebsam,Zhongxiang Sun,Benjamin K. Ayida,Stephen E. Webber,Yuefen Zhou,Qiang Zhao,Charles R. Kissinger,Richard E. Showalter,Amit Shah,(unknown),Rupal Patel,Laurie A. LeBrun,Ruhi Kamran,Maria V. Sergeeva,Darian M. Bartkowski,Thomas G. Nolan,Daniel A. Norris,(unknown)	10
3	Novel HCV NS5B polymerase inhibitors derived from 4-(1′,1′-dioxo-1′,4′-dihydro-1′λ6-benzo[1′,2′,4′]thiadiazin-3′-yl)-5-hydroxy-2H-pyridazin-3-ones. Part 5: Exploration of pyridazinones containing 6-amino-substituents 2008 ·Bioorganic & Medicinal Chemistry Letters ·Peter S. Dragovich,(unknown),David A. Ellis,Qing Han,Ruhi Kamran,Charles R. Kissinger,Laurie A. LeBrun,Lian‐Sheng Li,Douglas E. Murphy,(unknown),Rupal Patel,Frank Ruebsam,Maria V. Sergeeva,Amit Shah,Richard E. Showalter,Chinh Van Tran,(unknown),Stephen E. Webber,(unknown),Yuefen Zhou	20
4	Novel HCV NS5B polymerase inhibitors derived from 4-(1′,1′-dioxo-1′,4′-dihydro-1′λ6-benzo[1′,2′,4′]thiadiazin-3′-yl)-5-hydroxy-2H-pyridazin-3-ones. Part 2: Variation of the 2- and 6-pyridazinone substituents 2008 ·Bioorganic & Medicinal Chemistry Letters ·Yuefen Zhou,Lian‐Sheng Li,Peter S. Dragovich,Douglas E. Murphy,Chinh Van Tran,Frank Ruebsam,Stephen E. Webber,Amit Shah,(unknown),April M. Averill,Richard E. Showalter,Rupal Patel,Qing Han,Qiang Zhao,Thomas Hermann,Charles R. Kissinger,Laurie A. LeBrun,Maria V. Sergeeva	18
5	Novel HCV NS5B polymerase inhibitors derived from 4-(1′,1′-dioxo-1′,4′-dihydro-1′λ6-benzo[1′,2′,4′]thiadiazin-3′-yl)-5-hydroxy-2H-pyridazin-3-ones. Part 1: Exploration of 7′-substitution of benzothiadiazine 2008 ·Bioorganic & Medicinal Chemistry Letters ·Yuefen Zhou,Stephen E. Webber,Douglas E. Murphy,Lian‐Sheng Li,Peter S. Dragovich,Chinh Van Tran,Zhongxiang Sun,Frank Ruebsam,Amit Shah,(unknown),Richard E. Showalter,Rupal Patel,Bin Li,Qiang Zhao,Qing Han,Thomas Hermann,Charles R. Kissinger,Laurie A. LeBrun,Maria V. Sergeeva,(unknown)	26
6	Efficient synthesis of (1R,2S) and (1S,2R)-2-aminocyclopentanecarboxylic acid ethyl ester derivatives in enantiomerically pure form 2008 ·Tetrahedron Asymmetry ·Peter S. Dragovich,Douglas E. Murphy,(unknown),Sun Hee Kim,Lian‐Sheng Li,Frank Ruebsam,Zhongxiang Sun,Chinh Van Tran,Alan X. Xiang,Yuefen Zhou	6
7	Regiospecific Synthesis of Novel 6-Amino-5-hydroxypyridazin-3(2H)-ones 2008 ·Synthesis ·Peter S. Dragovich,(unknown),(unknown),David Ellis,Lian‐Sheng Li,Douglas E. Murphy,Frank Ruebsam,Chinh Van Tran,Yuefen Zhou	2
8	Efficient Large-Scale Synthesis of 2-Amino-5-methanesulfonylaminobenzenesulfonamide 2008 ·Synthetic Communications ·Peter S. Dragovich,Douglas E. Murphy,Chinh Van Tran,Frank Ruebsam	3
9	Efficient synthesis of 2,6-disubstituted-5-hydroxy-3-oxo-2,3-dihydro-pyridazine-4-carboxylic acid ethyl esters 2007 ·Tetrahedron Letters ·Douglas E. Murphy,Peter S. Dragovich,Benjamin K. Ayida,(unknown),Lian‐Sheng Li,Frank Ruebsam,(unknown),Zhongxiang Sun,Jingjing Zhao,Yuefen Zhou	20
10	Potent HCV NS5B Polymerase Inhibitors Derived From 5-Hydroxy-3(2H)-Pyridazinones: Part 1Exploration of Pyridazinone 4-Substituent Variation 2007 ·Antiviral Research ·(unknown),L LI,S. E. Webber,Peter S. Dragovich,Douglas E. Murphy,(unknown),Frank Ruebsam,Amit Shah,(unknown),Richard E. Showalter	3
11	Synthesis of New Pyridazinone Derivatives: 2,6-Disubstituted 5-Hydroxy-3(2H)-pyridazinone-4-carboxylic Acid Ethyl Esters 2007 ·Synthesis ·Yuefen Zhou,(unknown),Jingjing Zhao,Peter S. Dragovich,(unknown),(unknown),Douglas E. Murphy,Zhongxiang Sun,Chinh Tran,Benjamin K. Ayida,Frank Ruebsam,Stephen E. Webber	1
12	Regiospecific synthesis of 1,5-disubstituted-1H-pyrazoles containing differentiated 3,4-dicarboxylic acid esters via Suzuki coupling of the corresponding 5-trifluoromethane sulfonates 2006 ·Tetrahedron ·Peter S. Dragovich,(unknown),Benjamin K. Ayida,Lian‐Sheng Li,Douglas E. Murphy,Frank Ruebsam,Zhongxiang Sun,Yuefen Zhou	12
13	ChemInform Abstract: Peptidomimetics in Drug Design 1997 ·ChemInform ·Athanassios Giannis,Frank Ruebsam	5

About Frank Ruebsam

Frank Ruebsam is a scholar working on Hepatology, Organic Chemistry and Infectious Diseases, having authored 13 papers that have together received 205 indexed citations. Recurring topics across this work include Quinazolinone synthesis and applications (5 papers), Hepatitis C virus research (4 papers) and HIV/AIDS drug development and treatment (4 papers). The work is most often cited by research in Hepatology (53 citations), Organic Chemistry (116 citations) and Computational Theory and Mathematics (35 citations). Frank Ruebsam has collaborated with scholars based in China, Germany and United States. Frequent co-authors include Peter S. Dragovich, Douglas E. Murphy, Lian‐Sheng Li, Yuefen Zhou, Matthew Clark, Zhongxiang Sun, Eric A. Sigel, Heather A. Thomson, Louis M. Renzetti and Ce Wang. Their work appears in journals such as Journal of Medicinal Chemistry, Tetrahedron and Tetrahedron Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact